OTC Markets OTCPK - Delayed Quote USD
Hemagen Diagnostics, Inc. (HMGN)
0.0001
0.0000
(0.00%)
At close: June 11 at 8:00:00 PM EDT
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| HMGN | -- | -- | -- | -- |
| S&P 500 | 13.13% | 2.45% | 7.55% | 14.06% |
Related Tickers
ERGO Entia Biosciences, Inc.
0.0001
0.00%
CYCCP Cyclacel Pharmaceuticals, Inc.
5.45
+3.02%
OLMA Olema Pharmaceuticals, Inc.
4.0600
-0.49%
MNPR Monopar Therapeutics Inc.
33.82
-2.40%
GOSS Gossamer Bio, Inc.
1.2700
-1.55%
CYCC Cyclacel Pharmaceuticals, Inc.
0.3590
+13.75%
SCNI Scinai Immunotherapeutics Ltd.
2.3300
-2.10%
CAPR Capricor Therapeutics, Inc.
13.94
+6.09%
TPST Tempest Therapeutics, Inc.
7.11
-4.82%
ALT Altimmune, Inc.
7.15
+9.33%